| Source: |
| Type: |
| The Rho GTPases RhoA, Rac1, and Cdc42 are important regulators of cytoskeletal dynamics.
small GTPase Ras homolog gene family member A (RHOA) RHOA: Ras homolog family member A Many in vitro and in vivo data indicate tumor-promoting effects of activated Rho GTPases, also tumor suppressive functions have been described. In many cancers, RhoA and RhoC are often found to be overexpressed. RhoB expression can be downregulated in certain cancers, which may contribute to tumor progression. Unlike RhoA and RhoC, RhoB is often considered a tumor suppressor, and its loss can lead to increased cell proliferation and survival. -RhoA activity has been linked to the modulation of EMT, influencing both the disassembly of cell–cell junctions and the reorganization of the cytoskeleton necessary for migration. -Elevated levels or hyperactivation of RhoA has been associated with poor prognosis in several cancers. |
| Normal Healthy |
| 757- | Bor, | Phenylboronic acid is a more potent inhibitor than boric acid of key signaling networks involved in cancer cell migration |
| - | in-vitro, | Pca, | DU145 | - | in-vitro, | Nor, | RWPE-1 |
| 3227- | EGCG, | Epigallocatechin-3-gallate treatment to promote neuroprotection and functional recovery after nervous system injury |
| - | NA, | Nor, | NA |
| 3226- | EGCG, | Epigallocatechin-3-gallate, a green-tea polyphenol, suppresses Rho signaling in TWNT-4 human hepatic stellate cells |
| - | in-vitro, | Nor, | NA |
| 1713- | Lyco, | Lycopene: A Potent Antioxidant with Multiple Health Benefits |
| - | Review, | Nor, | NA |
| 3015- | RosA, | Rad, | Rosmarinic Acid Prevents Radiation-Induced Pulmonary Fibrosis Through Attenuation of ROS/MYPT1/TGFβ1 Signaling Via miR-19b-3p |
| - | in-vivo, | Nor, | IMR90 |
| 3012- | RosA, | Rad, | Rosmarinic Acid Prevents Radiation-Induced Pulmonary Fibrosis Through Attenuation of ROSMYPT1TGFβ1 Signaling Via miR-19b-3p |
| - | in-vitro, | Nor, | IMR90 |
| 3189- | SFN, | Sulforaphane Inhibits TNF-α-Induced Adhesion Molecule Expression Through the Rho A/ROCK/NF-κB Signaling Pathway |
| - | in-vitro, | Nor, | ECV304 |
Query results interpretion may depend on "conditions" listed in the research papers. Such Conditions may include : -low or high Dose -format for product, such as nano of lipid formations -different cell line effects -synergies with other products -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:49 Cells:% prod#:% Target#:273 State#:% Dir#:1
wNotes=0 sortOrder:rid,rpid